Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 5/20 | 0.59 |
| ▸ | CCR8 | P51685 | 5/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.59 |
| ▸ | CCR5 | P51681 | 3/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.57 |
| ▸ | MAPT | P10636 | 5/20 | 0.57 |
| ▸ | LMNA | P02545 | 4/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.57 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.57 |
| ▸ | HTT | P42858 | 2/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.57 |
| ▸ | MMP2 | P08253 | 2/20 | 0.57 |
| ▸ | TSHR | P16473 | 2/20 | 0.57 |
| ▸ | GMNN | O75496 | 1/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.57 |
| ▸ | MMP9 | P14780 | 1/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenanthroline SCHEMBL20503157 | 0.85 | L3MBTL1 (0.79) | CCR1CCR8L3MBTL1CCR5KDM4E | |
| SCHEMBL10884002 | 0.80 | SMN1; SMN2 (0.50) | CCR1CCR8L3MBTL1CCR5KDM4E | |
| SCHEMBL31290662 | 0.80 | SMN1; SMN2 (0.50) | CCR1CCR8L3MBTL1CCR5KDM4E | |
| Phenanthroline SCHEMBL3812011 | 0.78 | CCR1 (0.94) | CCR1CCR8L3MBTL1CCR5KDM4E | |
| SCHEMBL11942827 | 0.77 | HSP90AA1 (0.55) | CCR1CCR8L3MBTL1CCR5KDM4E | |
| SCHEMBL7635206 | 0.76 | CCR1 (0.67) | CCR1CCR8L3MBTL1CCR5KDM4E | |
| Phenanthroline SCHEMBL8845760 | 0.76 | CCR1 (1.00) | CCR1CCR8L3MBTL1CCR5KDM4E | |
| Phenanthroline SCHEMBL29367277 | 0.76 | CCR1 (1.00) | CCR1CCR8L3MBTL1CCR5KDM4E | |
| Phenanthroline SCHEMBL8312 | 0.76 | CCR1 (1.00) | CCR1CCR8L3MBTL1CCR5KDM4E | |
| Phenanthroline SCHEMBL29354015 | 0.76 | CCR1 (1.00) | CCR1CCR8L3MBTL1CCR5KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024144190-A1 | COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | 솔루스첨단소재 주식회사 | 2024-07-04 | — | — | WO | disclosed |
| US-9944846-B2 | Compositions for electronic applications | E I DU PONT DE NEMOURS AND COMPANY (US) | 2018-04-17 | — | — | US | disclosed |
| US-9496506-B2 | Deuterated compounds for electronic applications | E I DU PONT DE NEMOURS AND COMPANY (US) | 2016-11-15 | — | — | US | disclosed |
| US-20160060512-A1 | COMPOSITIONS FOR ELECTRONIC APPLICATIONS | LG CHEM, LTD. (KR) | 2016-03-03 | — | — | US | disclosed |
| US-20130140544-A1 | DEUTERATED COMPOUNDS FOR ELECTRONIC APPLICATIONS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-06-06 | — | — | US | disclosed |
| US-20120187382-A1 | ELECTRONIC DEVICES HAVING LONG LIFETIME | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2012-07-26 | — | — | US | disclosed |
| US-20110101312-A1 | DEUTERATED COMPOUNDS FOR ELECTRONIC APPLICATIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110101312-A1 | DEUTERATED COMPOUNDS FOR ELECTRONIC APPLICATIONS | VDAC3, NES, DRD3 | CCR1 3934/4885CCR8 2579/4885L3MBTL1 2998/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.